Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: a close above .13 looks pretty likely..imo

According to investor relations regarding the annual shareholder meeting:

We are hoping that the later scheduling of the meeting will afford an opportunity for the further development of matters important to the business to occur

If the settlement with Moore was not what was being referred to above, then perhaps there is something else of importance to be announced.

Share
New Message
Please login to post a reply